CareDx (CDNA)
(Delayed Data from NSDQ)
$12.22 USD
-0.07 (-0.53%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.22 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CDNA 12.22 -0.07(-0.53%)
Will CDNA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CDNA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CDNA
CareDx (CDNA) Surges 7.0%: Is This an Indication of Further Gains?
CareDx (CDNA) Tops Q1 Earnings Estimates
CDNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Elevance Health (ELV) Soars 5.4%: Is Further Upside Left in the Stock?
Here's Why Community Health's Florida Divestiture Matters
New Strong Buy Stocks for February 27th
Other News for CDNA
CareDx price target lowered by $4 at BTIG, here's why
BTIG Adjusts Price Target for CareDx (CDNA) Ahead of Q2 Earnings
CareDx to Report Second Quarter 2025 Financial Results | CDNA Stock News
CareDx Inc (CDNA) Trading 7.85% Higher on Jul 21
CareDx (CDNA): Analyst Rating Maintained, Price Target Lowered | CDNA Stock News